MX2010010795A - Uso de defensinas contra meningitis. - Google Patents
Uso de defensinas contra meningitis.Info
- Publication number
- MX2010010795A MX2010010795A MX2010010795A MX2010010795A MX2010010795A MX 2010010795 A MX2010010795 A MX 2010010795A MX 2010010795 A MX2010010795 A MX 2010010795A MX 2010010795 A MX2010010795 A MX 2010010795A MX 2010010795 A MX2010010795 A MX 2010010795A
- Authority
- MX
- Mexico
- Prior art keywords
- polypeptide
- meningitis
- polypeptides
- defensin
- amino acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Marine Sciences & Fisheries (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08154103 | 2008-04-04 | ||
PCT/EP2009/053726 WO2009121828A1 (en) | 2008-04-04 | 2009-03-30 | Use of defensins against meningitis |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010010795A true MX2010010795A (es) | 2011-01-12 |
Family
ID=40875112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010010795A MX2010010795A (es) | 2008-04-04 | 2009-03-30 | Uso de defensinas contra meningitis. |
Country Status (18)
Country | Link |
---|---|
US (1) | US20090253629A1 (pt) |
EP (1) | EP2278991A1 (pt) |
JP (1) | JP2011516450A (pt) |
KR (1) | KR20100134025A (pt) |
CN (1) | CN102036678A (pt) |
AP (1) | AP2010005403A0 (pt) |
AR (1) | AR071177A1 (pt) |
AU (1) | AU2009231463A1 (pt) |
BR (1) | BRPI0909021A2 (pt) |
CA (1) | CA2720380A1 (pt) |
CL (1) | CL2009000811A1 (pt) |
EA (1) | EA201071163A1 (pt) |
IL (1) | IL208189A0 (pt) |
MX (1) | MX2010010795A (pt) |
PE (1) | PE20091781A1 (pt) |
TW (1) | TW200942254A (pt) |
WO (1) | WO2009121828A1 (pt) |
ZA (1) | ZA201006645B (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201028154A (en) * | 2008-10-23 | 2010-08-01 | Novozymes As | Antibiotic synergism |
TW201125577A (en) * | 2009-12-02 | 2011-08-01 | Novozymes As | Use of defensins for treatment of infective endocarditis |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7338936B2 (en) * | 2000-11-28 | 2008-03-04 | House Ear Institute | Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis |
US20040265337A1 (en) * | 2002-08-21 | 2004-12-30 | Zsebo Krisztina M. | Method of generating an immune response and compositions used for same |
MX2007005520A (es) * | 2004-11-12 | 2007-07-09 | Novozymes As | Polipeptidos que tienen actividad antimicrobiana y polinucleotidos que codifican los mismos. |
EP1850861A1 (en) * | 2005-02-08 | 2007-11-07 | Novozymes A/S | Systemic treatment of infections with defensins |
AU2006256791B2 (en) * | 2005-06-06 | 2012-01-19 | Novozymes Adenium Biotech A/S | Polypeptides having antimicrobial activity and polynucleotides encoding same |
-
2009
- 2009-03-30 CA CA2720380A patent/CA2720380A1/en not_active Abandoned
- 2009-03-30 EP EP09727630A patent/EP2278991A1/en not_active Withdrawn
- 2009-03-30 WO PCT/EP2009/053726 patent/WO2009121828A1/en active Application Filing
- 2009-03-30 KR KR1020107022668A patent/KR20100134025A/ko not_active Application Discontinuation
- 2009-03-30 EA EA201071163A patent/EA201071163A1/ru unknown
- 2009-03-30 AP AP2010005403A patent/AP2010005403A0/en unknown
- 2009-03-30 MX MX2010010795A patent/MX2010010795A/es not_active Application Discontinuation
- 2009-03-30 JP JP2011502359A patent/JP2011516450A/ja active Pending
- 2009-03-30 CN CN2009801179800A patent/CN102036678A/zh active Pending
- 2009-03-30 BR BRPI0909021A patent/BRPI0909021A2/pt not_active IP Right Cessation
- 2009-03-30 AU AU2009231463A patent/AU2009231463A1/en not_active Abandoned
- 2009-03-31 US US12/414,745 patent/US20090253629A1/en not_active Abandoned
- 2009-04-02 PE PE2009000481A patent/PE20091781A1/es not_active Application Discontinuation
- 2009-04-02 TW TW098110960A patent/TW200942254A/zh unknown
- 2009-04-03 CL CL2009000811A patent/CL2009000811A1/es unknown
- 2009-04-03 AR ARP090101187A patent/AR071177A1/es unknown
-
2010
- 2010-09-16 ZA ZA2010/06645A patent/ZA201006645B/en unknown
- 2010-09-16 IL IL208189A patent/IL208189A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
AP2010005403A0 (en) | 2010-10-31 |
WO2009121828A1 (en) | 2009-10-08 |
ZA201006645B (en) | 2011-06-29 |
EP2278991A1 (en) | 2011-02-02 |
CA2720380A1 (en) | 2009-10-08 |
AR071177A1 (es) | 2010-06-02 |
BRPI0909021A2 (pt) | 2015-09-22 |
JP2011516450A (ja) | 2011-05-26 |
US20090253629A1 (en) | 2009-10-08 |
IL208189A0 (en) | 2010-12-30 |
PE20091781A1 (es) | 2009-12-03 |
KR20100134025A (ko) | 2010-12-22 |
EA201071163A1 (ru) | 2011-04-29 |
TW200942254A (en) | 2009-10-16 |
CL2009000811A1 (es) | 2010-05-07 |
CN102036678A (zh) | 2011-04-27 |
AU2009231463A1 (en) | 2009-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101155825B (zh) | 抗微生物六肽 | |
US6071879A (en) | Method for the treatment of bacterial infection | |
JP2009521932A (ja) | 抗菌性カテリシジンペプチド | |
CN103764669B (zh) | 抗炎药物产品 | |
US7745390B2 (en) | Antimicrobial peptides | |
KR102415734B1 (ko) | 신규한 항균 펩타이드 및 이의 용도 | |
JP5208135B2 (ja) | 組換え白血球阻害因子とヒルゲンのキメラタンパク質及びその薬物組成物 | |
JP4932731B2 (ja) | シグナルペプチド、核酸分子及び治療方法 | |
CA2388910C (en) | Antimicrobial activity of the first cationic cluster of human lactoferrin | |
JP2000511424A (ja) | ラクトフェリン変異体およびその使用 | |
US20150018268A1 (en) | Multivalent synthetic compounds as antibiotic treatment | |
MX2010010795A (es) | Uso de defensinas contra meningitis. | |
CN112194730B (zh) | 一种多肽ti-16及其用途 | |
CN102264383A (zh) | 胞内细菌感染的处理 | |
KR101624691B1 (ko) | 신규한 세크로핀 유사 항진균 펩타이드 및 그의 조성물 | |
US8653024B2 (en) | Use of AMPs for treatment of UTI/cystitis | |
US20240254175A1 (en) | Novel selective antimicrobial fusion peptides | |
KR20230163124A (ko) | 코로나바이러스 질환의 예방 또는 치료용 조성물 | |
AU2020204461A1 (en) | A method of in vivo treatment | |
KR20210154308A (ko) | 아메리카왕거저리 유충으로부터 유래된 펩타이드인 조포바신-1 및 이의 용도 | |
CN118767111A (zh) | 一种抗耐药菌活性肽Hydrostatin-AMP3在治疗细菌性脓毒症中的应用 | |
JP2002114704A (ja) | 抗菌剤 | |
WO2009074133A2 (de) | C-terminale ifapsoriasinfragmente als antimikrobielle peptide, deren herstellung und verwendung | |
US20110130326A1 (en) | Defensins for treatment of infective endocarditis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |